Picard Medical, Inc.
Picard Medical, Inc. (NYSE: PMI) is a medical technology company that develops, manufactures and sells total artificial heart systems through its wholly owned subsidiary, SynCardia Systems, LLC. Its SynCardia Total Artificial Heart replaces both ventricles and all four heart valves for patients with end-stage… From the company’s description.
In fiscal 2025, Picard Medical, Inc. reported revenue of $4.94M and a net loss of $27.00M. Its operating margin was −268.4%, and operations used $15.67M in cash. Over the twelve months to Jun 30, 2026, revenue was $6.30M.
Dotted labels explain each measure. is shown separately from the annual figures.
What Picard Medical, Inc. does
In the company’s own words
Picard Medical, Inc. (NYSE: PMI) is a medical technology company that develops, manufactures and sells total artificial heart systems through its wholly owned subsidiary, SynCardia Systems, LLC. Its SynCardia Total Artificial Heart replaces both ventricles and all four heart valves for patients with end-stage biventricular heart failure, primarily as a bridge to heart transplantation; the system includes an implanted device, external pneumatic drivers and connecting drivelines. The C2 Driver supports patients in hospital, while the portable Freedom Driver can allow some patients to continue treatment at home. Customers include hospitals and heart transplant centers, with devices used by cardiothoracic surgeons. SynCardia is developing the Emperor, a fully implantable artificial heart, and the Unicorn next-generation driver. The company reports more than 2,100 SynCardia heart implants across 27 countries and operates as a single business through SynCardia. SynCardia’s product development traces to 1985, with the business later known as CardioWest and then SynCardia; Picard Medical was formed as a holding company and acquired full ownership of SynCardia. Its website is www.syncardia.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- TUCSON, AZ
- Fiscal year end
- December
- CIK
- 2030617
- SIC
- 3841
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Picard Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Picard Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Picard Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Picard Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Picard Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”